
|Articles|April 8, 2008
GlaxoSmithKline's Rotarix gets regulatory green light
GlaxoSmithKline's vaccine, Rotarix, receives approval for use in children.
Advertisement
Treatments to prevent rotavirus-caused gastroenteritis will soon gain an addition now that a new vaccine has been approved by the Food & Drug Administration.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5






































